159 related articles for article (PubMed ID: 21075475)
1. Sojourn time and lead time projection in lung cancer screening.
Wu D; Erwin D; Rosner GL
Lung Cancer; 2011 Jun; 72(3):322-6. PubMed ID: 21075475
[TBL] [Abstract][Full Text] [Related]
2. Estimating key parameters in FOBT screening for colorectal cancer.
Wu D; Erwin D; Rosner GL
Cancer Causes Control; 2009 Feb; 20(1):41-6. PubMed ID: 18704710
[TBL] [Abstract][Full Text] [Related]
3. Inference of Sojourn Time and Transition Density using the NLST X-ray Screening Data in Lung Cancer.
Rahman F; Wu D
Med Res Arch; 2021 May; 9(5):. PubMed ID: 34765725
[TBL] [Abstract][Full Text] [Related]
4. Bayesian lead time estimation for the Johns Hopkins Lung Project data.
Jang H; Kim S; Wu D
J Epidemiol Glob Health; 2013 Sep; 3(3):157-63. PubMed ID: 23932058
[TBL] [Abstract][Full Text] [Related]
5. A projection of benefits due to fecal occult blood test for colorectal cancer.
Wu D; Erwin D; Rosner GL
Cancer Epidemiol; 2009 Oct; 33(3-4):212-5. PubMed ID: 19733140
[TBL] [Abstract][Full Text] [Related]
6. Estimating key parameters in periodic breast cancer screening-application to the Canadian National Breast Screening Study data.
Chen Y; Brock G; Wu D
Cancer Epidemiol; 2010 Aug; 34(4):429-33. PubMed ID: 20434974
[TBL] [Abstract][Full Text] [Related]
7. Estimation of sensitivity depending on sojourn time and time spent in preclinical state.
Kim S; Wu D
Stat Methods Med Res; 2016 Apr; 25(2):728-40. PubMed ID: 23129110
[TBL] [Abstract][Full Text] [Related]
8. Estimation of Preclinical State Onset Age and Sojourn Time for Heavy Smokers in Lung Cancer.
Wu D; Rai SN; Seow A
Stat Interface; 2022; 15(3):349-358. PubMed ID: 35936652
[TBL] [Abstract][Full Text] [Related]
9. A Bayesian model for estimating multi-state disease progression.
Shen S; Han SX; Petousis P; Weiss RE; Meng F; Bui AA; Hsu W
Comput Biol Med; 2017 Feb; 81():111-120. PubMed ID: 28038345
[TBL] [Abstract][Full Text] [Related]
10. Estimation of mean sojourn time for lung cancer by chest X-ray screening with a Bayesian approach.
Chien CR; Lai MS; Chen TH
Lung Cancer; 2008 Nov; 62(2):215-20. PubMed ID: 18400331
[TBL] [Abstract][Full Text] [Related]
11. Estimating age group-dependent sensitivity and mean sojourn time in colorectal cancer screening.
Sung NY; Jun JK; Kim YN; Jung I; Park S; Kim GR; Nam CM
J Med Screen; 2019 Mar; 26(1):19-25. PubMed ID: 30261804
[TBL] [Abstract][Full Text] [Related]
12. Small median tumor diameter at cure threshold (<20 mm) among aggressive non-small cell lung cancers in male smokers predicts both chest X-ray and CT screening outcomes in a novel simulation framework.
Goldwasser DL; Kimmel M
Int J Cancer; 2013 Jan; 132(1):189-97. PubMed ID: 22510979
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer screening results in the National Cancer Institute New York study.
Melamed MR
Cancer; 2000 Dec; 89(11 Suppl):2356-62. PubMed ID: 11147612
[TBL] [Abstract][Full Text] [Related]
14. Inference of Onset Age of Preclinical State and Sojourn Time for Breast Cancer.
Wu D; Kim S
Med Res Arch; 2022 Feb; 10(2):. PubMed ID: 35419489
[TBL] [Abstract][Full Text] [Related]
15. Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography.
Chien CR; Chen TH
Int J Cancer; 2008 Jun; 122(11):2594-9. PubMed ID: 18302157
[TBL] [Abstract][Full Text] [Related]
16. Results of Mayo lung project: an interim report.
Sanderson D; Fontana R
Recent Results Cancer Res; 1982; 82():179-86. PubMed ID: 6287546
[TBL] [Abstract][Full Text] [Related]
17. Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution.
Shen Y; Zelen M
Biostatistics; 2005 Oct; 6(4):604-14. PubMed ID: 15860542
[TBL] [Abstract][Full Text] [Related]
18. Bayesian inference for the lead time in periodic cancer screening.
Wu D; Rosner GL; Broemeling LD
Biometrics; 2007 Sep; 63(3):873-80. PubMed ID: 17825017
[TBL] [Abstract][Full Text] [Related]
19. Exploring the uncertainties of early detection results: model-based interpretation of mayo lung project.
Shi L; Tian H; McCarthy WJ; Berman B; Wu S; Boer R
BMC Cancer; 2011 Mar; 11():92. PubMed ID: 21375784
[TBL] [Abstract][Full Text] [Related]
20. MLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screening.
Wu D; Rosner GL; Broemeling L
Biometrics; 2005 Dec; 61(4):1056-63. PubMed ID: 16401279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
